LCG
PRAH

Lisanti Capital Growth’s PRA Health Sciences, Inc. PRAH Stock Holding History

Lisanti Capital Growth’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,990
Closed -$1.65M – 136
2019
Q1 		$1.65M Sell
14,990
-2,430
-14% -$254K 0.59% 76
2018
Q4 		$1.6M Buy
17,420
+11,865
+214% +$1.2M 0.65% 61
2018
Q3 		$612K Buy
+5,555
New +$578K 0.21% 102
2018
Q2 		– Sell
-30,524
Closed -$2.53M – 165
2018
Q1 		$2.53M Sell
30,524
-3,320
-10% -$295K 1.22% 28
2017
Q4 		$3.08M Buy
33,844
+2,155
+7% +$179K 1.77% 8
2017
Q3 		$2.41M Buy
31,689
+5,975
+23% +$452K 1.51% 14
2017
Q2 		$1.93M Buy
25,714
+2,070
+9% +$143K 1.28% 24
2017
Q1 		$1.54M Buy
23,644
+7,834
+50% +$461K 2.21% 2
2016
Q4 		$871K Buy
15,810
+5,485
+53% +$301K 1.05% 39
2016
Q3 		$583K Sell
10,325
-3,825
-27% -$188K 0.74% 68
2016
Q2 		$591K Buy
+14,150
New +$652K 0.89% 54
2016
Q1 		– Sell
-15,215
Closed -$689K – 119
2015
Q4 		$689K Buy
+15,215
New +$639K 0.72% 65

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Lisanti Capital Growth's PRAH Position: Q2 2019 in Review

Lisanti Capital Growth sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 14,990 shares — an estimated $1.65M sold.

Lisanti Capital Growth first reported a position in PRAH in Q4 2015 and held it in 12 quarters. The position peaked at $3.08M in Q4 2017. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • Lisanti Capital Growth reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Lisanti Capital Growth sold 14,990 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $1.65M.
  • Lisanti Capital Growth first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 12 quarters.
  • Lisanti Capital Growth's PRA Health Sciences, Inc. position peaked at $3.08M in Q4 2017.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Lisanti Capital Growth's 13F filing for Q2 2019, filed 5 Aug 2019.